These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 25116271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V, Lochman P, Pika T, Zapletalová J, Minařík J, Bačovský J.
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [Abstract] [Full Text] [Related]

  • 3. [Assessment of Heavy/ Light Chain Pairs of Immunoglobulin (Hevylite assay) -  Benefit for Stratification of Multiple Myeloma?].
    Ščudla V, Lochaman P, Pika T, Zapletalová J, Minařík J, Bačovský J.
    Klin Onkol; 2015; 28(5):359-69. PubMed ID: 26480864
    [Abstract] [Full Text] [Related]

  • 4. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
    Scudla V, Lochman P, Pika T, Minarik J, Zapletalova J, Bacovsky J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
    [Abstract] [Full Text] [Related]

  • 5. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
    Ludwig H, Milosavljevic D, Berlanga O, Zojer N, Hübl W, Fritz V, Harding S.
    Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
    [Abstract] [Full Text] [Related]

  • 6. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
    Eckold J, Poenisch W, Drogies T, Kratzsch J, Teupser D, Thiery J, Bruegel M.
    Clin Lab; 2014 Mar; 60(9):1491-500. PubMed ID: 25291945
    [Abstract] [Full Text] [Related]

  • 7. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
    Katzmann JA, Willrich MA, Kohlhagen MC, Kyle RA, Murray DL, Snyder MR, Rajkumar SV, Dispenzieri A.
    Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D, Lemaire-Ewing S, Denimal D, Bastie JN, Lafon I, Caillot D.
    Ann Biol Clin (Paris); 2013 Feb; 71(2):157-63. PubMed ID: 23587579
    [Abstract] [Full Text] [Related]

  • 9. Heavy/light chain assay in the monitoring of multiple myeloma.
    Ting HY, Sthaneshwar P, Bee PC, Shanmugam H, Lim M.
    Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E, Miravalles E, Bergón E, Miranda I, Bergón M.
    Clin Chem Lab Med; 2005 Aug; 43(1):32-7. PubMed ID: 15653439
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.
    Bradwell A, Harding S, Fourrier N, Mathiot C, Attal M, Moreau P, Harousseau JL, Avet-Loiseau H.
    Leukemia; 2013 Jan; 27(1):202-7. PubMed ID: 22699454
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
    Kyrtsonis MC, Vassilakopoulos TP, Kafasi N, Sachanas S, Tzenou T, Papadogiannis A, Galanis Z, Kalpadakis C, Dimou M, Kyriakou E, Angelopoulou MK, Dimopoulou MN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Panayiotidis P, Pangalis GA.
    Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
    [Abstract] [Full Text] [Related]

  • 17. Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients.
    Batinić J, Perić Z, Šegulja D, Last J, Prijić S, Dubravčić K, Volarić L, Sertić D, Radman I, Bašić-Kinda S, Matišić D, Batinić D, Labar B, Nemet D.
    Croat Med J; 2015 Jun; 56(3):263-71. PubMed ID: 26088851
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
    Ščudla V, Balcárková J, Lochman P, Vincová M, Pika T, Minařík J, Zapletalová J, Jarošová M.
    Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
    [Abstract] [Full Text] [Related]

  • 19. Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy.
    Wolff F, Debaugnies F, Rozen L, Willems D, Brohet F, Brauner J, Stordeur P.
    Clin Biochem; 2013 Jan; 46(1-2):79-84. PubMed ID: 23041246
    [Abstract] [Full Text] [Related]

  • 20. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI.
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.